Filter the drugs by their COVID-19 status ,phase of research and how they help

COVID-19 is a respiratory disease caused by the SARS-CoV-2 virus. Browse the database of potential drugs for COVID-19 treatment compiled by the AIM tool.
Substance COVID-19 status Phase of research How it helps Latest publication
NIH-CoVnb-112
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/22/2020
RBD-NVP
Potential treatment - pre-clinical evidence Experimental Vaccine Dec/20/2020
[5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyfuran-2-yl](sodiylium)methyl [({[5-(3-carbamoyl-1,4-dihydropyridin-1-yl)-3,4-dihydroxyfuran-2-yl]methoxy}(sodiooxo)phosphoryl)oxy]phosphonate
Potential treatment - theoretical effect Experimental Antiviral Dec/19/2020
NSC Ex/Mv
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/18/2020
2-(Morpholin-4-yl)-2-oxoethyl 6-(4-methoxyphenyl)-3-methyl-1-phenyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylate
Potential treatment - theoretical effect Experimental Antiviral Dec/17/2020
N-(3-(Furan-2-yl)-1-(4-methyl-6-oxo-1,6-dihydropyrimidin-2-yl)-1H-pyrazol-5-yl)-3-methylbenzamide
Potential treatment - theoretical effect Experimental Antiviral Dec/17/2020
N-[(2R)-2-(1H-Indol-3-yl)-2-thiophen-2-ylethyl]-2-oxo-1H-quinoline-4-carboxamide
Potential treatment - theoretical effect Experimental Antiviral Dec/17/2020
LV::SFL
Potential treatment - pre-clinical evidence Experimental Vaccine Dec/16/2020
rVSV-∆G-spike
Potential treatment - pre-clinical evidence Experimental Vaccine Dec/16/2020
dbq33b4p7
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/14/2020
2-Ethyl-7,10,11-trimethoxy-3,4-dihydro-1H-phenanthro[9,10-c]pyridin-4-ol
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/14/2020
Tylophorine
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/14/2020
NYBSP-1
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/11/2020
NYBSP-4
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/11/2020
NYBSP-2
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/11/2020
CIGB-325
Potential treatment - clinical evidence Experimental Antiviral Dec/11/2020
Ty1
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/11/2020
Octyl gallate
Potential treatment - theoretical effect Experimental Antiviral Dec/10/2020
SARS-CoV-2-IN-1
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/09/2020
MPI8
Potential treatment - pre-clinical evidence Experimental Antiviral Dec/07/2020